Edition:
United Kingdom

Vectura Group PLC (VEC.L)

VEC.L on London Stock Exchange

70.55GBp
19 Oct 2018
Change (% chg)

-1.40 (-1.95%)
Prev Close
71.95
Open
69.40
Day's High
71.75
Day's Low
68.90
Volume
546,812
Avg. Vol
1,215,404
52-wk High
127.22
52-wk Low
67.20

Chart for

About

Vectura Group plc is engaged in research, development and commercialization of therapeutic products and drug delivery systems for human use. The Company's products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) - LABA-LAMA; Seebri Breezhaler (EU and RoW) - LAMA; AirFluSal Forspiro (EU and RoW) -... (more)

Overall

Beta: 0.41
Market Cap(Mil.): £705.16
Shares Outstanding(Mil.): 679.34
Dividend: --
Yield (%): --

Financials

  VEC.L Industry Sector
P/E (TTM): -- 30.90 33.64
EPS (TTM): -- -- --
ROI: -- 14.75 14.27
ROE: -- 16.24 15.99

UPDATE 1-Vectura reviewing drug stockpiles as no-deal Brexit looms

Sept 11 British drugmaker Vectura Group Plc is reviewing its stockpiles of drugs and key components as part of its mitigation plan for a "no-deal" Brexit and warned on Tuesday of a potential disruption to supply chains and higher costs.

11 Sep 2018

Vectura reviewing drug stockpiles as no-deal Brexit looms

Sept 11 Vectura Group Plc is reviewing its stockpiles of drugs and key components as part of its plan for a "no-deal" Brexit, the British drugmaker said on Tuesday, and warned of a potential disruption to supply chains and higher costs.

11 Sep 2018

BRIEF-Sosei Says Does Not Intend To Make An Offer For Vectura

* CONFIRMS THAT IT DOES NOT INTEND TO MAKE AN OFFER FOR VECTURA

24 Apr 2018

Earnings vs. Estimates